complement in cystic fibrosi quantit and function assess were made of both the classic and altern pathway of complement activ in sera from 23 patient with cystic fibrosi the classic pathway function similarli in patient and control as measur by ch50 titr altern pathway function initi in patient sera by incub with inulin wa equal to that of control as determin by cleavag of factor b and c3 and by the consumpt of termin compon factor b howev wa more readili activ in patient than in control sera thi rapid alter of factor b did not lead to acceler or more extens activ of the termin complement compon via the altern pathway when assess by c3 cleavag and the consumpt of termin compon thu a complement defici wa not found the import of the easili activ factor b is undefin